Showing results (111-120 of 174) with videos related to

Sort By:
Pageof 18
Nature and Science of Sleep|June 9, 2021
Prevalence and Risk Factors Associated with Insomnia Symptoms Among the Chinese General Public After the Coronavirus Disease 2019 Epidemic Was Initially ControlledJunlong Guo, Lulu Yang, Yan Xu, et al.
Neuroscience Letters|January 30, 2007
Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disordersZhongchun Liu, Fan Zhu, Gaohua Wang, et al.
Virologica Sinica|April 10, 2016
The long non-coding RNA expression profile of Coxsackievirus A16 infected RD cells identified by RNA-seqYingying Shi, Huilin Tu, Xiong Chen, et al.
Psychiatry Research. Neuroimaging|November 11, 2017
Altered corticostriatal pathway in first-episode paranoid schizophrenia: Resting-state functional and causal connectivity analysesHuan Huang, Chang Shu, Jun Chen, et al.
Schizophrenia (Heidelberg, Germany)|May 20, 2023
Nicotinamide ameliorates mitochondria-related neuronal apoptosis and cognitive impairment via the NAD+/SIRT3 pathwayKeke Hao, Fashuai Chen, Linyao Zhao, et al.
Brain Imaging and Behavior|April 1, 2025
Effects of polygenic risk for major depressive disorder and childhood emotional neglect on cortical blood flow complexity in young depression patientsLijun Kang, Qian Gong, Wei Wang, et al.
Brain Sciences|May 1, 2025
Association of TRPV1 and the SIRT3/SOD2 Signaling Pathway in Mononuclear Cells and Astrocyte-Derived Extracellular Vesicles in Patients with SchizophreniaRui Xu, Hao Liu, Chang Shu, et al.
Psychiatry and Clinical Neurosciences|September 7, 2023
Human in vivo evidence of reduced astrocyte activation and neuroinflammation in patients with treatment-resistant depression following electroconvulsive therapyShu-Xian Xu, Xin-Hui Xie, Lihua Yao, et al.
Iscience|June 4, 2026
Integrative omics identify NID2 as a therapeutic target linking depression and colorectal cancer in humansLi Huang, Ji Wang, Haodong Tian, et al.
International Immunopharmacology|April 26, 2026
Inhibition of the PDGFRβ/MMP-9 pathway attenuates CUMS-induced blood-brain barrier disruption, neuroinflammation, and depressive-like behaviorsHanchun Yan, Wei Wang, Xinhua Song, et al.
Pageof 18